Gerard J. Nau

4.7k citations
63 papers · 3.7k indexed · 1 hit paper · h-index 31

Gerard J. Nau

63 papers receiving 3.7k citations

Hit Papers

Human macrophage activation programs induced by bacterial...5702002202620102018100200300400500

Peers

Gerard J. Nau
Comparison fields: 5 of 147
  • Immunology 1.1k
  • Endocrinology 174
  • Infectious Diseases 622
  • Molecular Medicine 157
  • Microbiology 192
Replace Naoya Kato with:
Naoya Kato Japan
Hui Wu United States
William H. Benjamin United States
Juan Antonio López Spain
Parviz Ahmad‐Nejad Germany
Thomas Miethke Germany
Erwin Bohn Germany
Xiang Qin United States
Aldo Tagliabue Italy
Hortense Slevogt Germany
Gerard J. Nau relative to Naoya Kato Japan Naoya Kato's profile →
Citations per field
00.5×3.2×
Naoya Kato · 1×
Citations per year

Countries citing papers authored by Gerard J. Nau

Since Specialization
Citations

This map shows the geographic impact of Gerard J. Nau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard J. Nau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard J. Nau more than expected).

Fields of papers citing papers by Gerard J. Nau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerard J. Nau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard J. Nau. The network helps show where Gerard J. Nau may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gerard J. Nau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerard J. Nau Line = papers co-authored together Gerard J. Nau links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20222
2 202095
3 20209
4 20193
5 2017139
6 20146
7 201322
8 201048
9 20101
10 200974
11 200881
12 200866
13 200837
14 2005367
15 200384
16
Human macrophage activation programs induced by bacterial pathogensbreakdown →
2002570
17 200071
18 19939
19 198817
20 198822

About Gerard J. Nau

Gerard J. Nau is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Immunology, having authored 63 papers that have together received 3.7k indexed citations. Recurring topics across this work include Bacillus and Francisella bacterial research (15 papers), Bacterial Genetics and Biotechnology (9 papers), Bacteriophages and microbial interactions (8 papers), Immune Response and Inflammation (7 papers), Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Immunology (1.1k citations), Endocrinology (174 citations) and Infectious Diseases (622 citations). Gerard J. Nau has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Richard A. Young, Ziv Bar‐Joseph, Jason Ernst, Dawn M. O’Dee, Ann Schlesinger, Cory M. Robinson, Eric S. Lander, Ezra G. Jennings, Jeffrey S. Berman and Geoffrey Chupp.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026